Gilead Sciences, Inc (NASDAQ: GILD) is 20.47% higher on its value in year-to-date trading and has touched a low of $62.07 and a high of $119.96 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GILD stock was last observed hovering at around $112.05 in the last trading session, with the day’s loss setting it -0.77%.
Currently trading at $111.28, the stock is -0.31% and 4.95% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.28 million and changing -0.69% at the moment leaves the stock 25.81% off its SMA200. GILD registered 51.92% gain for a year compared to 6-month gain of 33.09%. The firm has a 50-day simple moving average (SMA 50) of $106.0274 and a 200-day simple moving average (SMA200) of $88.45295.
The stock witnessed a -4.06% loss in the last 1 month and extending the period to 3 months gives it a 18.24%, and is 3.14% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.26% over the week and 2.36% over the month.
Gilead Sciences, Inc (GILD) has around 17600 employees, a market worth around $138.58B and $28.73B in sales. Current P/E ratio is 303.13 and Fwd P/E is 13.15. Profit margin for the company is 1.67%. Distance from 52-week low is 79.28% and -7.24% from its 52-week high. The company has generated returns on investments over the last 12 months (1.07%).
The EPS is expected to grow by 72.38% this year.
Gilead Sciences, Inc (GILD) Top Institutional Holders
2517.0 institutions hold shares in Gilead Sciences, Inc (GILD), with institutional investors hold 89.73% of the company’s shares. The shares outstanding are 1.25B, and float is at 1.24B with Short Float at 1.80%. Institutions hold 89.62% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 120.63 million shares valued at $8.28 billion. The investor’s holdings represent 9.6738% of the GILD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 115.26 million shares valued at $7.91 billion to account for 9.2431 of the shares outstanding. The other top investors are CAPITAL WORLD INVESTORS which holds 76.25 million shares representing 6.1147% and valued at over $5.23 billion, while CAPITAL RESEARCH GLOBAL INVESTORS holds 4.8458 of the shares totaling 60.43 million with a market value of $4.15 billion.
Gilead Sciences, Inc (GILD) Insider Activity
The most recent transaction is an insider sale by Dickinson Andrew D, the company’s Chief Financial Officer. SEC filings show that Dickinson Andrew D sold 2,500 shares of the company’s common stock on Mar 17 ’25 at a price of $110.53 per share for a total of $0.28 million. Following the sale, the insider now owns 0.17 million shares.
Still, SEC filings show that on Mar 10 ’25, Dickinson Andrew D (Chief Financial Officer) disposed off 17,929 shares at an average price of $118.17 for $2.12 million. The insider now directly holds 169,061 shares of Gilead Sciences, Inc (GILD).
